Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,177
Closed -$7.28M 192
2025
Q4
$7.71M Buy
7,177
+6,487
+940% +$6.2M 0.39% 20
2025
Q3
$526K Buy
+690
New +$513K 0.06% 46
2024
Q2
Sell
-499
Closed -$388K 22
2024
Q1
$388K Buy
+499
New +$355K 0.07% 24
2023
Q1
Sell
-296
Closed -$108K 95
2022
Q4
$108K Buy
+296
New +$105K 0.01% 136
2021
Q4
Sell
-860
Closed -$199K 169
2021
Q3
$199K Buy
860
+800
+1,333% +$197K 0.01% 288
2021
Q2
$14K Buy
+60
New +$12.1K ﹤0.01% 261

Other funds holding LLY

QVR's LLY Position: Q1 2026 in Review

QVR sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 7,177 shares — an estimated $7.28M sold.

QVR first reported a position in LLY in Q2 2021 and held it in 6 quarters. The position peaked at $7.71M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • QVR reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • QVR sold 7,177 Eli Lilly shares in Q1 2026, an estimated $7.28M.
  • QVR first reported a position in Eli Lilly in Q2 2021 and held it in 6 quarters.
  • QVR's Eli Lilly position peaked at $7.71M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on QVR's 13F filing for Q1 2026, filed 15 Apr 2026.